Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytotoxic lymphocytes, and uses therefor

Melanoma-specific, A1-restricted CTL epitopes have been identified in tyrosinase, and may be used in conjunction with other A1-, A2- and/or A3-restricted epitopes of tyrosinase, pMel-17 and other melanoma antigens in the design of vaccines.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DONALD F HUNT, DAVID KITTLESEN, CRAIG L SLINGLUFF, JONATHAN SKIPPER, ANDREA L COX, RONALD C. HENDRIKSON, VICTOR H ENGELHARD, JEFFREY SHABANOWITZ
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Melanoma-specific, A1-restricted CTL epitopes have been identified in tyrosinase, and may be used in conjunction with other A1-, A2- and/or A3-restricted epitopes of tyrosinase, pMel-17 and other melanoma antigens in the design of vaccines.